Gilead Sciences (GILD) Return on Equity [ROE] (2009 - 2026)
Gilead Sciences (GILD) posted Return on Equity [ROE] of -31.17% for Q3 2026, down 70.61 percentage points from 39.44% a year earlier and down 12.80 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences' Return on Equity [ROE] came in at 40.57%, up 38.29 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +40.14 percentage points (FY2020 to FY2025).
- In prior years, Gilead Sciences' Return on Equity [ROE] was 2.29% in FY2024 (-23.25 pp), 25.54% in FY2023 (+3.94 pp), 21.60% in FY2022 (-9.97 pp) and 31.57% in FY2021 (+31.13 pp).
- The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2009.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of -0.60 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 38.81 percentage points; the weakest was Q3 2026, with a drop of 70.61 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -18.38% (Q2 2026), 39.95% (Q1 2026) and 38.47% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,249.15 Bn | 1,222.76 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 672.28 Bn | 592.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.12 Bn | 483.13 Bn | 13.12 Bn | - |
| 4 | Merck | 364.35 Bn | 327.29 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.18 Bn | 288.42 Bn | - | - |
| 6 | Astrazeneca | 292.81 Bn | 266.70 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.17 Bn | 200.82 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.23 Bn | 185.34 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 165.64 Bn | 113.00 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 19.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -31.17% |
| Jun 30, 2026 | -18.38% |
| Mar 31, 2026 | 39.95% |
| Dec 31, 2025 | 38.47% |
| Sep 30, 2025 | 39.44% |
| Jun 30, 2025 | 32.64% |
| Mar 31, 2025 | 31.13% |
| Dec 31, 2024 | 2.55% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | 5.79% |
| Mar 31, 2024 | 2.28% |
| Dec 31, 2023 | 24.95% |
| Sep 30, 2023 | 26.90% |
| Jun 30, 2023 | 25.90% |
| Mar 31, 2023 | 26.28% |
| Dec 31, 2022 | 21.61% |
| Sep 30, 2022 | 16.04% |
| Jun 30, 2022 | 20.48% |
| Mar 31, 2022 | 21.92% |
| Dec 31, 2021 | 29.16% |
API Access
Gilead Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();